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Background. Introduction. In this descriptive study the clinical and neurological issues related 
to CHARGE syndrome (C – coloboma, cranial nerves; H – heart defects; A – atresia of the 
choanae; R – retardation in growth, mental development, G – genital abnormalities, E – ear 
malformation / hearing loss) were assessed. The study presents the clinical examination of one 
case with typical form of pathology, along with the identification of diagnosis and treatment 
particularities.  Aim of study. Being a relatively rarely encountered disease, it requires a 
separate attitude from both patients and medical staff. The aim of the study is the identification 
of typical existing forms of the disease, in order to determine the principles and methods of 
diagnosis and treatment.  
Case report. Materials and methods. A 19 years old boy was admitted to the Institute of 
Neurology and Neurosurgery, Chisinau, Republic of Moldova in February, 2020 being 
evaluated according to clinical methods (investigation, anthropometry) and laboratory tests.  
Ressults. The patient’s complaints were: hearing impairment, memory loss, pain in thoracic 
and lumbar spine, headache, asthenia, myalgia. Neurological examination: hyposmia; the 
presence of hearing loss in left ear, and hypoacusis in the right ear; unsteady Romberg’s 
position; diffuse hypotonia. Somatic examination: BMI = 14,7 kg/m2 (hyponutrition), regular 
pulse, BP = 120/90 mmHg.  Patient presents major criteria: atresia of choane, cranial nerve 
dysfunction – I, VIII, IX, and minor criteria: rhomboencephalic dysfunction including sensorial 
deafness, hypothalamo-hypophyseal dysfunction (gonadotropin or growth hormone 
deficiency) - genital hypoplasia and growth deficiency, characteristic facial features, 
intellectual disability, feeding difficulties, skeletal anomalies – thoracic and lumbar scoliosis 
grade 2 with rib block T8-T10. Atypical signs: immunodeficiency, gastroesophageal reflux, 
sleepiness, vestibular abnormalities. Prior to establishing the final diagnosis, the differential 
diagnosis was: Rubinstein-Taybi syndrome and Oppenheim amyotonia.  The CHARGE 
syndrome is an autosomal dominant genetic condition caused by a mutation in the CHD7 gene. 
The patient has 2 sisters, 24 and 21 years old, who are also diagnosed with CHARGE 
syndrome. They both are pregnant, and the risk of passing on the syndrome to their offsprings 
is very high. Early appropriate investigations of the syndrome facilitate a correct diagnosis and 
proper management. Given the number of affected systems in CHARGE syndrome, we believe 
that a multidisciplinary clinical model is beneficial in the management of these children: the 
general paediatrician, genetic diagnosis, otolaryngologist, ophthalmologist, cardiologist.  
Conclusions. The patient manifests a typical phenotype of CHARGE syndrome according to 
the Verloes’s criteria. The diagnosis is usually made on clinical grounds. It requires a genetic 
test to confirm the CDH7 mutation in order to identify the individual’s and their offsprings’ 
risk and to initiate an early targeted therapy.  
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Background.  Multiple sclerosis (MS) is a central nervous system disorder characterized by 
inflammation, demyelination and neurodegeneration, and is the most common cause of 
acquired nontraumatic neurological disability in young adults. The course of the disease varies 
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between individuals: some patients accumulate minimal disability over their lives, whereas 
others experience a rapidly disabling disease course. A part of patients with multiple sclerosis 
presents also seizures that lead to epilepsy.   Several clinical series reported an association 
between multiple sclerosis and epilepsy. The most studies show an increased comorbidity 
between multiple sclerosis and epilepsy. The cumulative incidence of epilepsy by 10 years after 
diagnosis of MS was 1.9%. The probable anatomic basis for the seizures is areas of 
inflammation, edema, and/or demyelination in the cerebral cortex and the juxtacortical white 
matter generated by a mechanism that is not completely understood; the fact that these plaques 
are very common suggests that other factors must operate in view of the rarity of seizures in 
MS. In most cases, however, the prognosis of epilepsy was good and there seemed not to be 
any clear correlation between the severity of MS and epilepsy.   
Case report.  A patient V. male, 41 years , came at a neurologist in April 2019 with the 
following complaints: facial hyperemia, heat sensations, alterations of consciousness with 
convulsive components in the anamnesis. At the same time: walking instability, recurrent 
diplopia, frequent urination, sleeping disorders, memory loss and decrease in body mass.   
Anamnesis: In 2005 patient has an acute respiratory infection, possible a flu. After a half a year 
had appeared diplopia, diplopia and frequent urination. In 2007 the diagnosis of multiple 
sclerosis was established. The diagnosis was confirmed in Moscow and the patient started the 
treatment with Galatimer acetate (Copaxone) that he administered for 5 years with the 
improvement of the evolution of the disease. Subsequently administered Acsoglatiran till 
present but without any obvious effect.   In 2015 the patient has a seizure for the first time with 
unconsciousness but without warning signs. Other signs and symptoms associated with 
unconsciousness the patient doesn’t remember. A similar episode was in 2017. In 2019 the 
patient received symptomatic treatment in the neurology department for diagnosis: Multiple 
sclerosis clinically and imagistic defined, recurrent remissive form, in exacerbation, with 
pronounced atactic syndrome. Structural epilepsy-mesial temporal sclerosis on the right 
associated to multiple sclerosis plague with focal seizures with bilateral passage treated with 
Carbamazepine retard 300 mg/day. Now the antiepileptic treatment is Timonil 750 mg/day 
with a very good outcome.   
Conclusions.  MS is a risk factor for developing epilepsy. Patients with MS have a threefold 
increase in risk for developing epilepsy when compared with that expected in the general 
population. The reason for this increased risk is unclear and needs further investigation.   
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Background.  Collecting duct carcinoma is located in the renal medulla and it originates from 
the collecting duct epithelium. It involves about 1% from all renal epithelial malignancies. 
